Accéder directement au contenu Accéder directement à la navigation
Article dans une revue

Which antiretrovirals should be prescribed as first-line treatments? Changes over the past 10 years in France

Abstract : OBJECTIVE: To describe the changes in first-line antiretroviral (ART) regimens in France between 2005 and 2015 and patients' characteristics related to the use of protease inhibitors in 2015. METHODS: We extracted all patients starting ART between 2005 and 2015 from a large prospective cohort. Regimens were classified as three nucleoside reverse transcriptase inhibitors (NRTI), or two NRTIs with a boosted protease inhibitor (bPI), with a non-nucleoside reverse transcriptase inhibitor (NNRTI), or with an INSTI. Patients' characteristics at the time of initiation were collected. A multinomial logit model was fitted to analyze characteristics related to the choice of regimen in 2015. RESULTS: We analyzed data from 15,897 patients. The proportion of patients starting with (i) a bPI decreased from 60% before 2014 to 38.1% in 2015; (ii) an NNRTI decreased from 30% to 17.8% in 2015; (iii) an INSTI gradually increased to 39.4% in 2015. In 2015, patients with an initial viral load ˃5 log copies/mL were less likely to receive NNRTI (OR=0.08) or INSTI regimens (OR=0.69) than bPIs. Patients with initial CD4+ T cell count ˂200/mm3 were less likely to receive an NNRTI (OR=0.28) or an INSTI regimen (OR=0.52) than a bPI. Women were less likely to receive an NNRTI (OR=0.79) or an INSTI regimen (OR=0.71) than a bPI; although this depended on age. CONCLUSION: The use of bPI as first-line ART declined sharply in France from 2005 to 2015. bPI remained of preferential use in patients with high viral load, low CD4+ T cell count, and in women.
Liste complète des métadonnées

https://hal.umontpellier.fr/hal-02565217
Contributeur : Amandine Michel-Avella <>
Soumis le : mercredi 6 mai 2020 - 11:50:42
Dernière modification le : vendredi 15 mai 2020 - 12:22:09

Identifiants

Citation

P. Pugliese, V. Joly, M.A. Valantin, L. Cotte, T. Huleux, et al.. Which antiretrovirals should be prescribed as first-line treatments? Changes over the past 10 years in France. Medecine Et Maladies Infectieuses, Elsevier, 2019, 49 (4), pp.264-269. ⟨10.1016/j.medmal.2018.10.005⟩. ⟨hal-02565217⟩

Partager

Métriques

Consultations de la notice

23